CIK 0001842952 · <br>Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863738787
- Phone
- 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-24 | Pasternak Andy Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2026-06-24 | Stacey Jennifer Evans Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2026-06-24 | West Linda Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2026-06-24 | Smith Karen L. Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2026-06-24 | Walker Luke Nathaniel Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2026-06-24 | Kantoff Philip W. Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2026-02-19 | Levit Alex C. Chief Legal Officer, Corp. Sec | Grant or award · Stock Option (right to buy) | +270,000 | 270,000 | ||
| 2026-02-19 | Minai-Azary Jennifer Lynn Chief Financial Officer | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2026-02-19 | Chagin Karen Deborah Chief Medical Officer | Grant or award · Stock Option (right to buy) | +290,000 | 290,000 | ||
| 2026-02-19 | Lehr Martin A. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +815,000 | 815,000 | ||
| 2025-06-12 | Pasternak Andy Director | Grant or award · Stock Option (right to buy) | +138,900 | 138,900 | ||
| 2025-06-12 | Kantoff Philip W. Director | Grant or award · Stock Option (right to buy) | +123,500 | 123,500 | ||
| 2025-06-12 | Smith Karen L. Director | Grant or award · Stock Option (right to buy) | +123,500 | 123,500 | ||
| 2025-06-12 | Stacey Jennifer Evans Director | Grant or award · Stock Option (right to buy) | +123,500 | 123,500 | ||
| 2025-06-12 | Walker Luke Nathaniel Director | Grant or award · Stock Option (right to buy) | +123,500 | 123,500 | ||
| 2025-06-12 | West Linda Director | Grant or award · Stock Option (right to buy) | +123,500 | 123,500 | ||
| 2025-06-09 | Lehr Martin A. Chief Executive Officer | Purchase | +100,000 | $0.70 | $70K | 920,190 |
| 2025-06-09 | Chagin Karen Deborah Chief Medical Officer | Grant or award · Stock Option (right to buy) | +153,000 | 153,000 | ||
| 2025-06-06 | Levit Alex C. Chief Legal Officer, Corp. Sec | Purchase | +20,000 | $0.58 | $12K | 29,000 |
| 2025-06-06 | Minai-Azary Jennifer Lynn Chief Financial Officer | Purchase | +40,010 | $0.64 | $25K | 80,010 |
Page 1 of 5 · 85 trades